September 26, 2022
Connecticut is slated to provide legal, state-supported MDMA and psilocybin therapy as early as next year. The northeast state seeks to provide qualified patients with funding to receive MDMA-assisted or psilocybin-assisted therapy as part of a Food and Drug Administration expanded access program.
Full articleSeptember 8, 2022
San Francisco lawmakers have unanimously approved a measure calling for the decriminalization of psychedelics like psilocybin and ayahuasca. While it doesn’t immediately enact changes to criminal justice policy in San Francisco, it urges police to deprioritize psychedelics as “amongst the lowest priority” for enforcement and requests that “City resources not be used for any investigation, detention, arrest, or prosecution...
Full articleAugust 24, 2022
In this double-blind randomized clinical trial with 93 participants, the percentage of heavy drinking days during 32 weeks of follow-up was significantly lower in the psilocybin group than in the diphenhydramine group.
Full articleMay 8, 2022
Where does Massachusetts stand on drug reform policy? What is the future of Massachusetts in terms of decriminalizing entheogens and lowering incarceration rates? Find out more about Bill H2119 as it aims to decriminalize not the use of drugs, but rather the people who use them.
Full articleMarch 8, 2022
Thousands of people in Oregon are interested in using psilocybin as a mental health treatment and hundreds are interested in becoming licensed to treat patients or offer services under the voter-approved program. Among more than 4,400 people who responded to a survey by the Oregon Health Authority, nearly 4,200 said they would like to access services...
Full article